<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592023000100027</article-id>
<article-id pub-id-type="doi">10.19136/hs.a22n1.4882</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de tratamientos alternativos en pacientes del área de oncología en el noreste de México]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of alternative treatments in patients in the oncology area in northeastern Mexico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas-Ruiz]]></surname>
<given-names><![CDATA[Hernán Uziel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas-González]]></surname>
<given-names><![CDATA[Domingo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Padrón]]></surname>
<given-names><![CDATA[Hadassa Yuef]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Regional de Alta Especialidad de Ciudad Victoria &#8220;Bicentenario 2010&#8221;  ]]></institution>
<addr-line><![CDATA[Ciudad Victoria Tamaulipas]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Regional de Alta Especialidad de Ciudad Victoria &#8220;Bicentenario 2010&#8221;  ]]></institution>
<addr-line><![CDATA[Ciudad Victoria Tamaulipas]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Regional de Alta Especialidad de Ciudad Victoria &#8220;Bicentenario 2010&#8221;  ]]></institution>
<addr-line><![CDATA[Ciudad Victoria Tamaulipas]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2023</year>
</pub-date>
<volume>22</volume>
<numero>1</numero>
<fpage>27</fpage>
<lpage>33</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592023000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592023000100027&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592023000100027&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  Determinar la prevalencia del uso complementario de la herbolaria en pacientes de oncología.  Materiales y Métodos:  El presente estudio fue de tipo observacional, transversal, descriptivo y prolectivo. Se llevó a cabo un muestreo no probabilístico. En el estudio se incluyeron a 100 pacientes que acudieron al área de oncología del Hospital de Alta Especialidad de Ciudad Victoria &#8220;Bicentenario 2010&#8221; (HRAEV) durante el periodo del estudio y que cumplieron con los criterios de selección señalados para esta investigación.  Resultados:  Se realizaron 100 encuestas a pacientes oncológicos, de los cuales el 55% fue de sexo femenino. Dicha población presenta una edad promedio de 48.2 años. Respecto al origen de los pacientes, el 67% radica en Cd. Victoria. El rango de nivel educativo entre los entrevistados osciló entre preparatoria y secundaria. Los cuales pertenecen a clase media. Existe una prevalencia del 82% en el uso de tratamientos alternativos para tratar la patología, de los cuales el 76% emplea el uso de la herbolaria como coadyuvante en las diferentes enfermedades que se tratan en el hospital. Las principales plantas empleadas son: la Mariguana (Cannabis sativa) en un 45%, el 23% Noni (Morinda citrifolia) y el 12% Bardana (Arctium lappa).  Conclusión:  El uso de la medicina alternativa complementaria es frecuente en pacientes oncológicos, destacando la herbolaria. Por lo anterior, el comprender la dinámica de la implementación de terapias alternativas como lo es la herbolaria, permitirá comprender y guiar al paciente en su proceso de ciclos oncológicos y minimizar los efectos secundarios.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Objective:  To determine the prevalence of the complementary use of herbal medicine in oncology patients.  Materials and methods:  This study was observational, cross-sectional, descriptive and prolective. A non-probabilistic sampling was carried out. The study included 100 patients who attended the oncology area of the Hospital de Alta Especialidad de Ciudad Victoria "Bicentenario 2010" (HRAEV) during the study period and who met the selection criteria indicated for this research.  Results:  100 surveys were carried out on cancer patients, of which 55% were female. This population has an average age of 48.2 years. Regarding the origin of the patients, 67% reside in Cd. Victoria. The range of educational level among the interviewees oscillated between high school and middle school. who belong to the middle class. There is a prevalence of 82% in the use of alternative treatments to treat the pathology, of which 76% employ the use of herbal medicine as an adjuvant in the different diseases that are treated in the hospital. The main plants used are: 45% Marijuana (Cannabis sativa), 23% Noni (Morinda citrifolia) and 12% Burdock (Arctium lappa).  Conclusion:  The use of complementary alternative medicine is common in cancer patients, highlighting herbal medicine. Due to the above, understanding the dynamics of the implementation of alternative therapies such as herbalism, will allow understanding and guiding the patient in their oncological cycle process and minimizing side effects. KEY WORDS: naturopathy; oncology; alternative medicine.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer]]></kwd>
<kwd lng="es"><![CDATA[Oncología]]></kwd>
<kwd lng="es"><![CDATA[Tratamiento]]></kwd>
<kwd lng="en"><![CDATA[Cancer]]></kwd>
<kwd lng="en"><![CDATA[Oncology]]></kwd>
<kwd lng="en"><![CDATA[Therapy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<source><![CDATA[Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019]]></source>
<year>2020</year>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>IARC</collab>
<source><![CDATA[Latest Global Cancer Data: Cancer Burden Rises to 18.1 million new cases and 9.6 million cancer deaths in 2018]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aldaco-Sarvide]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Pérez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cervantes-Sánchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Torrecillas-Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Argentina Erazo-Valle-Solís]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera-Galeana]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Motola-Kuba]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Anaya]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Rivera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Cárdenas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad por cáncer en México: actualización2015]]></article-title>
<source><![CDATA[Gac Me Onc]]></source>
<year>2018</year>
<volume>17</volume>
<page-range>28-34</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>SMeO</collab>
<source><![CDATA[Prevención y diagnóstico oportuno en cáncer]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<source><![CDATA[Tipos de tratamientos contra el cáncer]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shu-Yi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wen-Chi]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[1 Feng-Yin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[1 Ning-Sun]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic applications of herbal medicines for cancer patients. &#8220;Evidence-based complementary and alternative medicine]]></article-title>
<source><![CDATA[eCAM]]></source>
<year>2013</year>
<volume>2013</volume>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomez-Martinez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tlacuilo-Parra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Garibaldi-Covarrubias]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of complementary and alternative medicine in children with cancer in Occidental, Mexico]]></article-title>
<source><![CDATA[Pediatr Blood Cancer]]></source>
<year>2007</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>820-3</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tello-Ortega]]></surname>
<given-names><![CDATA[K. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Santiago]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Ortíz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicina alternativa complementaria en el tratamiento de enfermedades crónicas en el sur de Oaxaca, México]]></article-title>
<source><![CDATA[CIENCIA ergo-sum]]></source>
<year>2020</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isaac-Otero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Molina-Alonso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Asencio-López]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Leal-Leal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de la medicina alternativa y complementaria (MAC) en cáncer infantil: encuesta de 100 casos en un instituto del tercer nivel de atención]]></article-title>
<source><![CDATA[Gac me mex]]></source>
<year>2016</year>
<volume>152</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>196-201</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro-Hernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Reynoso-Noverón]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[De la Piedra-Gómez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Encuesta sobre el uso de medicina alternativa y complementaria en pacientes mexicanos con cáncer atendidos en un centro de referencia oncológico]]></article-title>
<source><![CDATA[Gac Mex Onc]]></source>
<year>2018</year>
<volume>17</volume>
<page-range>237-44</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<source><![CDATA[Guía de Society for Integrative Oncology]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y geografía</collab>
<source><![CDATA[]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horneber]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bueschel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dennert]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Less]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ritter]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zwahlen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis]]></article-title>
<source><![CDATA[Integr Cancer Ther]]></source>
<year>2012</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>187-203</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<collab>Secretaría de Salud</collab>
<article-title xml:lang=""><![CDATA[Norma Oficial Mexicana NOM-004-SSA3-2012, Del expediente clínico]]></article-title>
<source><![CDATA[Diario Oficial de la Federación]]></source>
<year>2012</year>
<page-range>30-46</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rashad]]></surname>
<given-names><![CDATA[UM]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Gezawy]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[El-Gezawy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Azzaz]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer]]></article-title>
<source><![CDATA[J Laryngol Otol]]></source>
<year>2008</year>
<volume>19</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Motallebnejad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Akram]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moghadamnia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Moulana]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Omidi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of topical application of pure honey on radiation-induced mucositis: A randomized clinical trial]]></article-title>
<source><![CDATA[J Contemp Dent Pract]]></source>
<year>2008</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>40-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlación entre las búsquedas sobre terapias complementarias en Google y su uso por parte de la población española]]></article-title>
<source><![CDATA[Panace@]]></source>
<year>2016</year>
<volume>17</volume>
<numero>44</numero>
<issue>44</issue>
<page-range>124-32</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lortet-Tieulent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Georges]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Vaccarella]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Profiling global cancer incidence and mortality by socioeconomic development]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>2020</year>
<volume>147</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3029-36</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Baxter]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effectiveness of tai chi in breast cancer patients: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Complement Ther Clin Pract]]></source>
<year>2020</year>
<volume>38</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voiß]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dobos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kümmel]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Komplementäre Therapien in der Onkologie]]></article-title>
<source><![CDATA[Gynäkologe]]></source>
<year>2019</year>
<volume>52</volume>
<page-range>135-43</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voiß]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dobos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kümmel]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lebensstilfaktoren und Komplementärmedizin beim Mammakarzinom]]></article-title>
<source><![CDATA[Gynäkologe]]></source>
<year>2017</year>
<volume>50</volume>
<page-range>525-32</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abrams]]></surname>
<given-names><![CDATA[D. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Guzman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cannabis in cancer care]]></article-title>
<source><![CDATA[Clin pharm therap]]></source>
<year>2015</year>
<volume>97</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>575-86</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vanini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Barbieri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Heck]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de plantas medicinales por pacientes oncológicos y familiares en un centro de radioterapia]]></article-title>
<source><![CDATA[Enf Glob]]></source>
<year>2011</year>
<volume>2011</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arslan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ozdemir]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancer]]></article-title>
<source><![CDATA[Clin J Oncol Nurs]]></source>
<year>2015</year>
<volume>19</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>E92-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of olive leaf extract in decreasing the expression of two pro-inflammatory cytokines in patients receiving chemotherapy for cancer. A randomized clinical trial]]></article-title>
<source><![CDATA[Saudi Dent J]]></source>
<year>2013</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>141-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[C.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[C.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[H.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Chuang]]></surname>
<given-names><![CDATA[H.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[S.Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tsao]]></surname>
<given-names><![CDATA[G.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[C.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J.Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesión molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells]]></article-title>
<source><![CDATA[Int. J. Mol. Sci]]></source>
<year>2015</year>
<volume>16</volume>
<page-range>2530-58</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Y.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[S.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gan]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[Y.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[S.L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[(-)-Epigallocatechin-3-gallateinhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-kappaB p65 inactivation]]></article-title>
<source><![CDATA[Tumour. Biol]]></source>
<year>2015</year>
<volume>36</volume>
<page-range>2747-61</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[C.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[P.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Tu]]></surname>
<given-names><![CDATA[M.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[C.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuo]]></surname>
<given-names><![CDATA[S.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Amagaya]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[C.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Jao]]></surname>
<given-names><![CDATA[H.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[M.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[J.S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic e_ects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2]]></article-title>
<source><![CDATA[Oncol. Rep]]></source>
<year>2012</year>
<volume>28</volume>
<page-range>1799-807</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
